Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Cyclotron-produced /sup 62/Zn: its possible use in prostate and pancreas scanning as a /sup 62/Zn amino acid chelate. [Rats, dogs, monkeys, /sup 65/Zn]

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:7094378
Zinc-62 is a positron emitter that localizes in pancreas, prostate, and liver. Cyclotron-produced Zn-62 was separated by column chromatography and evaluated in vivo as the chelate of five amino acids and also as /sup 62/ZnCl/sub 2/. Tissue-distribution studies were done in normal animals from 0.7 to 23 hr after intravenous administration. Pancreas-to-liver ratios (per gram) of about 1.0 were found at 1.5 hr in studies on rats, dogs, and monkeys. Pancreas was as difficult to separate from liver in Zn-62 (amino acid) images as in (/sup 75/Se) selenomethionine images. Some studies were done with Zn-65 to determine the effects of carrier zinc and molar ratios of ligand. The highest ratio of pancreas to liver in these studies was 1.44. This uptake ratio decreases with increasing amounts of histidine, but ratio is increased by adding carrier zinc because there results a decrease in liver uptake and no change in the pancreas uptake. There is sufficient specificity of pancreas and prostate uptake to make feasible emission computed tomography with Zn-62.
Research Organization:
Univ. of California, Berkeley
OSTI ID:
7094378
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 18:8; ISSN JNMEA
Country of Publication:
United States
Language:
English